Literature DB >> 23295690

Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease?

Tomas de Wouters1, Joël Doré, Patricia Lepage.   

Abstract

Human biology can only be fully assessed by combining an analysis of both the host and its surrounding environment. As a part of the environment, the human gastrointestinal tract hosts more than 100 trillion bacteria making up the gut microbiota. The human host provides a nutrient-rich environment while the microbiota provides indispensable functions that humans cannot exert themselves. Shifts in the bacterial makeup of the human gut microbiota have been associated with disorders such as inflammatory bowel disease (IBD), irritable bowel syndrome and obesity. However, since most bacteria inhabiting our gut are not cultivable to date, until recently little was known about their individual functions. Metagenomics, i.e. the analysis of the collective genomes present in a defined ecosystem, gives insight into these specific functions. The first extensive catalogue of the intestinal metagenome outnumbers the size of the human genome by a factor of 150. Recently, 3 distinct 'types' of gut composition within the human population have been highlighted. These so-called 'enterotypes' are characterized by the dominant genera (Bacteroides, Prevotella and Ruminococcus) and their co-occurring phylogenetic groups. In accordance with the previously described impact of nutritional behavior (diet, probiotics and prebiotics) on specific bacterial populations, an association has been observed between long-term dietary habits and enterotypes. This recent discovery, i.e. that belonging to one or the other enterotype might be modulated by the diet opens up new perspectives in the fields of IBD, nutrition and therapeutic strategies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23295690     DOI: 10.1159/000342595

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  9 in total

1.  The lung microbiome. A new frontier in pulmonary medicine.

Authors:  James P Kiley; Elisabet V Caler
Journal:  Ann Am Thorac Soc       Date:  2014-01

2.  Independence of gut bacterial content and neonatal necrotizing enterocolitis severity.

Authors:  Lauren K Barron; Barbara B Warner; Phillip I Tarr; William D Shannon; Elena Deych; Brad W Warner
Journal:  J Pediatr Surg       Date:  2017-04-05       Impact factor: 2.545

Review 3.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  Inflammatory bowel disease: An archetype disorder of outer environment sensor systems.

Authors:  Giovanni C Actis; Floriano Rosina
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-08-06

Review 5.  Protective links between vitamin D, inflammatory bowel disease and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Lillian Maggio-Price; Jisun Paik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  Dietary factors and microRNA-binding site polymorphisms in the IL13 gene: risk and prognosis analysis of colorectal cancer.

Authors:  Yanming Yu; Junde Zhou; Chen Gong; Zhiping Long; Jingshen Tian; Lin Zhu; Jing Li; Hongyuan Yu; Fan Wang; Yashuang Zhao
Journal:  Oncotarget       Date:  2017-07-18

Review 7.  The Microbiome and Alzheimer's Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations.

Authors:  Karan Arora; Miranda Green; Satya Prakash
Journal:  Front Bioeng Biotechnol       Date:  2020-12-14

8.  Geriatric Respondents and Non-Respondents to Probiotic Intervention Can be Differentiated by Inherent Gut Microbiome Composition.

Authors:  Suja Senan; Jashbhai B Prajapati; Chaitanya G Joshi; V Sreeja; Manisha K Gohel; Sunil Trivedi; Rupal M Patel; Himanshu Pandya; Uday Shankar Singh; Ajay Phatak; Hasmukh A Patel
Journal:  Front Microbiol       Date:  2015-09-08       Impact factor: 5.640

9.  Is obesity a risk factor for vaccine non-responsiveness?

Authors:  Katherine M Young; Clive M Gray; Linda-Gail Bekker
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.